Fortitude Family Office’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Fortitude Family Office's AMGN Position: Q2 2026 in Review
Fortitude Family Office reduced its Amgen (AMGN) stake by 0.51% in Q2 2026, selling an estimated $2.05K and leaving 1,172 shares worth $424K. The position accounts for 0.08% of the portfolio, ranked #99.
Fortitude Family Office first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $853K in Q4 2025. 1,465 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Fortitude Family Office held 1,172 shares of Amgen worth $424K as of Q2 2026.
- Fortitude Family Office sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
- Amgen made up 0.08% of Fortitude Family Office's portfolio in Q2 2026, its #99 holding.
- Fortitude Family Office first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- Fortitude Family Office's Amgen position peaked at $853K in Q4 2025.
- 1,465 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.